Literature DB >> 8026278

HCV infection and hepatocellular carcinoma in cirrhotics: what is the linkage?

M Coltorti, N Caporaso, M Persico, I de Sio, R Marmo, F Morisco, C Tuccillo, M Romano.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8026278     DOI： 10.1007/bf02088075

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  5 in total

1.  Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

Authors:  B Bressac; K M Galvin; T J Liang; K J Isselbacher; J R Wands; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis.

Authors:  J Bruix; J M Barrera; X Calvet; G Ercilla; J Costa; J M Sanchez-Tapias; M Ventura; M Vall; M Bruguera; C Bru
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

3.  Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma.

Authors:  M Colombo; G Kuo; Q L Choo; M F Donato; E Del Ninno; M A Tommasini; N Dioguardi; M Houghton
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

4.  Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis.

Authors:  N Caporaso; M Romano; R Marmo; I de Sio; F Morisco; A Minerva; M Coltorti
Journal:  J Hepatol       Date:  1991-05       Impact factor: 25.083

5.  Decision-making model for a non-invasive diagnosis of compensated liver cirrhosis.

Authors:  R Marmo; M Romano; I de Sio; A Peduto; N Caporaso; M Persico; M Coltorti
Journal:  Ital J Gastroenterol       Date:  1993-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.